These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 21992511

  • 1. Successful use of tocilizumab in a patient with nephrotic syndrome due to a rapidly progressing AA amyloidosis secondary to latent tuberculosis.
    Magro-Checa C, Navas-Parejo Casado A, Borrego-García E, Raya-Álvarez E, Rosales-Alexander JL, Salvatierra J, Caballero-Morales T, Gómez-Morales M.
    Amyloid; 2011 Dec; 18(4):235-9. PubMed ID: 21992511
    [Abstract] [Full Text] [Related]

  • 2. Tocilizumab treatment for nephrotic syndrome due to amyloidosis in Behcet's disease.
    Redondo-Pachón MD, Enríquez R, Sirvent AE, Andrada E, Noguera-Pons R, Millán I, Amorós F.
    Ren Fail; 2013 Dec; 35(4):547-50. PubMed ID: 23472940
    [Abstract] [Full Text] [Related]

  • 3. Tocilizumab histologically improved AA renal amyloidosis in a patient with multicentric Castleman disease: A case report
.
    Yamada Y, Ueno T, Irifuku T, Nakashima A, Doi S, Ichinohe T, Masaki T.
    Clin Nephrol; 2018 Sep; 90(3):232-236. PubMed ID: 29701172
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. No regression of renal amyloid mass despite remission of nephrotic syndrome in a patient with TRAPS following etanercept therapy.
    Simsek I, Kaya A, Erdem H, Pay S, Yenicesu M, Dinc A.
    J Nephrol; 2010 Sep; 23(1):119-23. PubMed ID: 20091495
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Successful use of a humanized anti-interleukin-6 receptor antibody, tocilizumab, to treat amyloid A amyloidosis complicating juvenile idiopathic arthritis.
    Okuda Y, Takasugi K.
    Arthritis Rheum; 2006 Sep; 54(9):2997-3000. PubMed ID: 16947531
    [Abstract] [Full Text] [Related]

  • 11. Use of tocilizumab in amyloid a nephropathy associated with Sweet syndrome: a case report and literature review.
    Giannese D, Ferro F, Moriconi D, Bonadio AG, Elefante E, Egidi MF, Cupisti A, Baldini C.
    CEN Case Rep; 2021 Feb; 10(1):23-29. PubMed ID: 32681397
    [Abstract] [Full Text] [Related]

  • 12. Successful treatment of AA amyloidosis secondary to Hodgkin's disease with 4'-iodo-4'-deoxydoxorubicin.
    Pérez Equiza E, Arguiñano JM, Gastearena J.
    Haematologica; 1999 Jan; 84(1):93-4. PubMed ID: 10091401
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Renal amyloidosis secondary to childhood tuberculosis: a report of two cases.
    Krishnamurthy S, Samanta D, Yadav S.
    J Postgrad Med; 2009 Jan; 55(2):121-3. PubMed ID: 19550057
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Two cases of idiopathic multicentric Castleman disease with nephrotic syndrome treated with tocilizumab.
    Furutera N, Fukunaga N, Okita J, Suzuki T, Suenaga Y, Oyama Y, Aoki K, Fukuda A, Nakata T, Uesugi N, Daa T, Hisano S, Shibata H.
    CEN Case Rep; 2021 Feb; 10(1):35-41. PubMed ID: 32715375
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.